ČCHENG-TU, Čína, 10. júna 2023 /PRNewswire/ — Príslušné orgány v Číne schválili 8. júna 2023 v rámci oprávnenia na núdzové použitie (EUA) rekombinantnú trivalentnú vakcínu (XBB.1.5+BA.5+Delta) na báze proteínu COVID-19 (bunky Sf9) s názvom Coviccine® Trivalent XBB.1.5, vyvinutú…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.